Tyche Industries Limited Stock

Equities

TYCHE6

INE443B01012

Pharmaceuticals

Market Closed - Bombay S.E. 06:18:46 2024-05-03 am EDT 5-day change 1st Jan Change
207.8 INR +0.14% Intraday chart for Tyche Industries Limited -5.44% +11.72%
Sales 2022 630M 7.55M Sales 2023 756M 9.06M Capitalization 1.43B 17.14M
Net income 2022 93M 1.11M Net income 2023 142M 1.7M EV / Sales 2022 1.2 x
Net cash position 2022 658M 7.89M Net cash position 2023 726M 8.7M EV / Sales 2023 0.93 x
P/E ratio 2022
15.2 x
P/E ratio 2023
10.1 x
Employees 166
Yield 2022
1.09%
Yield 2023
1.43%
Free-Float 28.22%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.14%
1 week-5.44%
Current month-1.75%
1 month+15.28%
3 months+16.55%
6 months+23.29%
Current year+11.72%
More quotes
1 week
206.30
Extreme 206.3
221.85
1 month
187.25
Extreme 187.25
230.00
Current year
160.15
Extreme 160.15
230.00
1 year
157.60
Extreme 157.6
230.00
3 years
105.00
Extreme 105
270.00
5 years
35.95
Extreme 35.95
349.90
10 years
17.55
Extreme 17.55
349.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 98-11-13
Director of Finance/CFO - 17-05-29
Compliance Officer - 23-07-31
Members of the board TitleAgeSince
Chief Executive Officer 52 98-11-13
Director/Board Member 38 14-08-10
Director/Board Member 49 19-03-24
More insiders
Date Price Change Volume
24-05-03 207.8 +0.14% 35,304
24-05-02 207.5 -1.89% 15,303
24-04-30 211.5 -2.20% 14,677
24-04-29 216.2 -1.59% 8,340
24-04-26 219.8 +1.29% 11,870

Delayed Quote Bombay S.E., May 03, 2024 at 06:18 am EDT

More quotes
Tyche Industries Limited is an India-based company engaged in manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates of APIs. The Company operates through the Bulk Drugs segment. Its APIs include Sertraline HCI, Racecadotril, Palonosetron HCI, Silodosin, Solifenacin Succinate, Tamsulosin HCI, Tenofovir Disoproxil Fumarate, Tenofovir Alafenamide Fumarate, Atazanavir, Rupatadine Fumarate, Glucosamine HCI, Glucosamine Sulfate KCL, Glucosamine Sulfate NaCl, Nitrofurantoin Monohydrate, Nitrofurantoin Anhydrous and Nitrofurantoin Macrocrystal and others. Its intermediates include 4-(3,4-Dichlorophenyl)-1-tetralone, 1-Benzylpiperidine-4-Carboxaldehyde (BPCA), 3-Hydroxymethyl quinuclidine Hcl, and others. Its chiral intermediates include S-(+)-3-Quinuclidinol, R-(-)-3-Quinuclidinol and others. The Company's nutraceuticals include Glucosamine Hydrochloride, Glucosamine Sulfate Potassium Chloride and Glucosamine Sulfate Sodium Chloride.
More about the company
  1. Stock Market
  2. Equities
  3. TYCHE6 Stock